Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial
View/ Open
Author
Tresserra-Rimbau, Anna
Medina-Remón, Alexander
Martínez-González, Miguel A
López-Sabater, M Carmen
Covas, María I
Corella, Dolores
Salas-Salvadó, Jordi
Gómez-Gracia, Enrique
Lapetra, José
Arós, Fernando
Fiol, Miquel
Ros, Emili
Serra-Majem, Lluis
Pintó, Xavier
Muñoz, Miguel A
Gea, Alfredo
Ruiz-Gutiérrez, Valentina
Estruch, Ramón
Lamuela-Raventós, Rosa M
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1186/1741-7015-12-77Metadata
Show full item recordCitation
Tresserra-Rimbau, A., E. B. Rimm, A. Medina-Remón, M. A. Martínez-González, M. C. López-Sabater, M. I. Covas, D. Corella, et al. 2014. “Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial.” BMC Medicine 12 (1): 77. doi:10.1186/1741-7015-12-77. http://dx.doi.org/10.1186/1741-7015-12-77.Abstract
Background: Polyphenols may lower the risk of cardiovascular disease (CVD) and other chronic diseases due to their antioxidant and anti-inflammatory properties, as well as their beneficial effects on blood pressure, lipids and insulin resistance. However, no previous epidemiological studies have evaluated the relationship between the intake of total polyphenols intake and polyphenol subclasses with overall mortality. Our aim was to evaluate whether polyphenol intake is associated with all-cause mortality in subjects at high cardiovascular risk. Methods: We used data from the PREDIMED study, a 7,447-participant, parallel-group, randomized, multicenter, controlled five-year feeding trial aimed at assessing the effects of the Mediterranean Diet in primary prevention of cardiovascular disease. Polyphenol intake was calculated by matching food consumption data from repeated food frequency questionnaires (FFQ) with the Phenol-Explorer database on the polyphenol content of each reported food. Hazard ratios (HR) and 95% confidence intervals (CI) between polyphenol intake and mortality were estimated using time-dependent Cox proportional hazard models. Results: Over an average of 4.8 years of follow-up, we observed 327 deaths. After multivariate adjustment, we found a 37% relative reduction in all-cause mortality comparing the highest versus the lowest quintiles of total polyphenol intake (hazard ratio (HR) = 0.63; 95% CI 0.41 to 0.97; P for trend = 0.12). Among the polyphenol subclasses, stilbenes and lignans were significantly associated with reduced all-cause mortality (HR =0.48; 95% CI 0.25 to 0.91; P for trend = 0.04 and HR = 0.60; 95% CI 0.37 to 0.97; P for trend = 0.03, respectively), with no significant associations apparent in the rest (flavonoids or phenolic acids). Conclusions: Among high-risk subjects, those who reported a high polyphenol intake, especially of stilbenes and lignans, showed a reduced risk of overall mortality compared to those with lower intakes. These results may be useful to determine optimal polyphenol intake or specific food sources of polyphenols that may reduce the risk of all-cause mortality. Clinical trial registration ISRCTN35739639.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102266/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:12717399
Collections
- HMS Scholarly Articles [17922]
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)